Research Study

A PHASE 3, MULTI CENTER, OPEN-LABEL EXTENSION STUDY OF ORAL OZANIMOD FOR MODERATELY TO SEVERLY ACTIVE CROHN'S DISEASE
Principal Investigator 
Baljinder Salh

Overview

Body Locations and Systems 
Crohn's Disease
ClinicalTrials.gov# 
NCT03467958
Status 
Recruiting
Study Start/End 
Mar 21, 2019 to Mar 31, 2020
Locations 
Diamond Health Care Centre
Name/Title 
Graciela Tanjuatco. Research Coordinator
Phone 
604-875-5224
Purpose of Study 

The purpose of this study is to evaluate safety and efficacy of ozanimod in subjects with moderately to severely active Crohn's Disease.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.